The Connection for the Collection®
My One Medical Source® (MOMS) (myonemedicalsource.com) earns a Brand Analyzer score of 66 out of 100, placing it in the Developing tier among Healthcare brands, SaaS brands. Among 2305 Healthcare brands analyzed, My One Medical Source® (MOMS) ranks in the 37th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 85/100, Digital Presence 71/100, Visual Identity 93/100, Messaging Clarity 95/100, Trust Foundation 68/100, AI Discoverability 73/100, Brand Authority 15/100.
My One Medical Source® (MOMS) is a healthcare SaaS platform operating at myonemedicalsource.com. Operating under the tagline 'The Connection for the Collection®,' MOMS connects specialty laboratories with more than 2,440 credentialed specimen collection providers across all 50 U.S. states. The platform enables instant, compliant access to specimen collection services, serving specialty labs, credentialed collection providers (MAPs), and patients nationwide.
| Brand Name | My One Medical Source® (MOMS) |
|---|---|
| Domain | myonemedicalsource.com |
| Industry | Healthcare, SaaS |
| Main Competitors | Labcorp (84/100), Quest Diagnostics (80/100), Sonic Healthcare (70/100), BioReference Laboratories (71/100), Precision Diagnostics |
Moz Domain Authority 24/100 vs category average 29 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "MOMS® connects specialty labs with 2,440+ credentialed specimen collection providers across all 50 states. The Connection for the Collection®." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Instagram, YouTube; no detected presence on X (Twitter), LinkedIn, Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
My One Medical Source® (MOMS) scores 20/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
My One Medical Source® (MOMS) has a weak AI-visibility profile at 20/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (55/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 24/100.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
My One Medical Source® (MOMS)'s main competitors include Labcorp (84/100), Quest Diagnostics (80/100), Sonic Healthcare (70/100), BioReference Laboratories (71/100), Precision Diagnostics. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
My One Medical Source® (MOMS) and Labcorp are competitors in Healthcare. Brand Analyzer scores My One Medical Source® (MOMS) at 66/100 and Labcorp at 84/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Popular alternatives to My One Medical Source® (MOMS) include Labcorp (84/100), Quest Diagnostics (80/100), Sonic Healthcare (70/100), BioReference Laboratories (71/100), Precision Diagnostics. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
MOMS offers a SaaS-based platform that connects specialty laboratories with credentialed specimen collection providers. Core service features described include instant connection capabilities, nationwide coverage across all 50 U.S. states, and compliance-oriented access to a network of 2,440+ credentialed providers. The platform serves three primary user groups - specialty labs, credentialed specimen collection providers (referred to as MAPs), and patients - suggesting differentiated access or functionality for each group.
My One Medical Source® (MOMS) is a healthcare SaaS platform that serves as a nationwide connection hub between specialty laboratories and credentialed specimen collection providers. Operating under the registered tagline 'The Connection for the Collection®,' MOMS functions across all 50 U.S. states. The platform is designed to facilitate compliant, instant linkages among specialty labs, collection providers, and patients, positioning itself as the leading nationwide platform in its category.
My One Medical Source® (MOMS) has low AI-search visibility, scoring 20/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 22, recommendation 55). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
My One Medical Source® (MOMS) is known for its registered brand identity as 'The Connection for the Collection®' and for operating the leading nationwide platform that links specialty labs with credentialed specimen collection providers. It is particularly recognized for its scale - connecting over 2,440 credentialed providers across all 50 U.S. states - and for enabling compliant, instant access to specimen collection services for specialty laboratories.
My One Medical Source® (MOMS) is used by three primary audiences: specialty laboratories that require specimen collection services, credentialed specimen collection providers (referred to as MAPs) who offer those services, and patients who are the end recipients of specimen collection. The platform's nationwide reach - covering all 50 U.S. states and engaging over 2,440 credentialed providers - indicates broad utilization across the healthcare specimen collection ecosystem.
My One Medical Source® (MOMS) scores 55/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
My One Medical Source® (MOMS) can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
MOMS addresses a specific operational need in the healthcare industry: connecting specialty labs with qualified specimen collection providers quickly and compliantly across a large geographic footprint. Its network of 2,440+ credentialed providers spanning all 50 states suggests meaningful adoption among specialty labs and collection providers. The platform's emphasis on instant, compliant access at scale addresses practical challenges laboratories face in sourcing reliable specimen collection services nationwide.
Ranked closest to My One Medical Source® (MOMS): Momentm Technologies (66/100), Modulim (66/100), TeamCare (66/100), New Horizons Dental Care (66/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).